rbd003

Robert B. Den, MD

Contact Dr. Den

111 South 11th Street
Room G-301, Bodine Center
Philadelphia, PA 19107

(215) 955-6702
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. Prognostic outlier genes for enhanced prostate cancer treatment
  2. Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer
  3. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality
  4. Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes
  5. Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential
  6. Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy—A Multi-Institutional Observational Study
  7. ASTRO APEx® and RO-ILS™ are applicable to medical malpractice in radiation oncology
  8. Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
  9. Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
  10. Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy
  11. Reply to Nicola Fossati, Giorgio Gandaglia, Alberto Bossi, Francesco Montorsi, Alberto Briganti's Letter to the Editor re: Stephen J. Freedland, Voleak Choeurng, Lauren Howard, et al. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy After Radical Prostatectomy. Eur Urol 2016;70:588–96
  12. Radioisotopes in management of metastatic prostate cancer
  13. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy
  14. Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome
  15. The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate Cancer
  16. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study
  17. The landscape of prognostic outlier genes in high-risk prostate cancer
  18. Patient-level DNA damage and repair pathway profiles and prognosis after prostatectomy for high-risk prostate cancer
  19. Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities
  20. Dosing, administration, and safety of radium-223: How i do it